Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
π‘ Key Point: Nimodipine is given after aneurysmal subarachnoid haemorrhage (SAH) to reduce the risk of delayed cerebral vasospasm and secondary ischaemia. It should be started as soon as possible (within 4 days) and continued for 21 days under specialist guidance.
Indication | Route | Typical Dose / Duration | Notes |
---|---|---|---|
Aneurysmal SAH | Oral / NG | 60 mg (2 Γ 30 mg) every 4 hours for 21 days | Start within 4 days of SAH. If hypotension develops, reduce to 30 mg 4-hourly. |
Unable to take orally | IV infusion | 0.5β2 mg/hour (max 2 mg/h) | Begin at 0.5 mg/h (or lower if <70 kg), increase after 2 h if BP stable. |
RCVS (off-label) | Oral / IV | As per SAH protocol (under neurologist guidance) | Used to reduce vasoconstriction and headache frequency. |